Pulsenmore Ltd. Ordinary Shares (PLSM)

FairStock Score: 24/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses with durable economics and a margin of safety, and Pulsenmore does not show either in the figures provided. It makes portable ultrasound devices—a useful medical niche—but at 71 employees and a $23.4M market cap, it is a small player with no evident moat. The stock closed at $1.90 on 2026-10-13. FairStock’s negative P/E of -1.36 signals losses, while ROE of -45.21% and ROCE of -6.98% show capital is being consumed, not compounded. The Piotroski F-Score of 2/9 and Altman Z-Score of -2.35 are weak signs for financial health. The one bright spot is low leverage: D/E of 0.02. But low debt does not rescue a business that is not earning money. Growth is hard to judge: revenue growth and profit growth are N/A, and FairStock cannot assign a Lynch category because there are only 0 years of filed results, needing three. The 52-week range of $1.75 to $12.97 shows how far sentiment has fallen. A collapsing price can tempt bargain hunters, but Graham would ask where the earnings and assets are; Buffett would ask whether the competitive advantage is durable. Here, the evidence points to a speculative medical-device venture, not a value investment. I would need to see filed evidence of rising sales, narrowing losses, and a credible path to positive cash flow before the numbers could support a margin of safety.

In plain English: Pulsenmore makes portable ultrasound machines for medical care. The business looks weak: it is losing money, has a very short reporting history, and its financial health measures are poor. The share price has fallen sharply from its high, but without steady profits it is hard to call the stock cheap; it looks risky and speculative.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer